| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 国际贸易(元) | 8,434,398,596.48 | 6,836,368,835.08 | 8,766,054,989.07 | 3,618,339,703.82 |
| 医药工业(元) | 3,335,489,330.13 | 1,721,315,792.83 | 3,582,322,790.99 | 1,706,723,551.72 |
| 医药商业(元) | 29,287,561,515.27 | 16,981,049,287.85 | 27,393,271,172.22 | 12,660,048,673.45 |
| 内部抵销(元) | -2,233,018,937.03 | -3,913,762,689.22 | -2,148,999,419.37 | -333,658,093.93 |
| 其他主营业务(元) | - | - | - | -333,658,093.93 |
| 营业成本(元) | ||||
| 国际贸易(元) | 7,684,357,551.75 | 6,398,005,311.77 | 7,811,583,209.33 | 3,073,830,656.24 |
| 医药工业(元) | 2,045,767,341.51 | 1,005,348,977.89 | 2,088,336,617.07 | 952,717,781.76 |
| 医药商业(元) | 26,936,113,663.54 | 15,752,876,080.92 | 25,101,628,961.75 | 11,566,632,860.86 |
| 内部抵销(元) | -2,225,424,872.76 | -3,935,111,548.67 | -2,155,762,912.91 | -321,238,232.52 |
| 其他主营业务(元) | - | - | - | -321,238,232.52 |
| 毛利(元) | ||||
| 国际贸易(元) | 750,041,044.73 | 438,363,523.31 | 954,471,779.74 | 544,509,047.58 |
| 医药工业(元) | 1,289,721,988.62 | 715,966,814.94 | 1,493,986,173.92 | 754,005,769.96 |
| 医药商业(元) | 2,351,447,851.73 | 1,228,173,206.93 | 2,291,642,210.47 | 1,093,415,812.59 |
| 内部抵销(元) | -7,594,064.27 | 21,348,859.45 | 6,763,493.54 | -12,419,861.41 |
| 其他主营业务(元) | - | - | - | -12,419,861.41 |
| 毛利率(%) | ||||
| 国际贸易(%) | 8.89 | 6.41 | 10.89 | 15.05 |
| 医药工业(%) | 38.67 | 41.59 | 41.70 | 44.18 |
| 医药商业(%) | 8.03 | 7.23 | 8.37 | 8.64 |
| 内部抵销(%) | 0.34 | -0.55 | -0.31 | 3.72 |
| 其他主营业务(%) | - | - | - | 3.72 |
| 收入构成(%) | ||||
| 国际贸易(%) | 21.72 | 31.61 | 23.32 | 20.89 |
| 医药工业(%) | 8.59 | 7.96 | 9.53 | 9.86 |
| 医药商业(%) | 75.44 | 78.53 | 72.87 | 73.10 |
| 内部抵销(%) | -5.75 | -18.10 | -5.72 | -1.93 |
| 其他主营业务(%) | - | - | - | -1.93 |
| 毛利构成(%) | ||||
| 国际贸易(%) | 17.11 | 18.24 | 20.11 | 23.00 |
| 医药工业(%) | 29.42 | 29.78 | 31.47 | 31.85 |
| 医药商业(%) | 53.64 | 51.09 | 48.28 | 46.19 |
| 内部抵销(%) | -0.17 | 0.89 | 0.14 | -0.52 |
| 其他主营业务(%) | - | - | - | -0.52 |